Intercept Pharmaceuticals (ICPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/29/20
Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback?The Motley Fool • 07/01/20
Biotech Crashes To 7-Year Low On Surprise FDA Rejection In Liver DiseaseInvestors Business Daily • 06/29/20
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Intercept Pharmaceuticals, Inc.Business Wire • 06/29/20
FDA Tells Intercept Pharmaceuticals No on Its NASH Drug Candidate -- for NowThe Motley Fool • 06/29/20
Intercept Pharmaceuticals receives FDA Complete Response Letter for treatment for fibrosis due to NASHMarket Watch • 06/29/20
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASHGlobeNewsWire • 06/29/20
Intercept Pharmaceuticals Shares Fall 13% After FDA Delays an Advisory Committee MeetingThe Motley Fool • 05/22/20
Intercept Pharmaceuticals Stock Dives On Unexpected Delay For NASH DrugInvestors Business Daily • 05/22/20